122 related articles for article (PubMed ID: 34245171)
1. Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma.
Mikoshiba T; Ozawa H; Watanabe Y; Kawaida M; Sekimizu M; Saito S; Yoshihama K; Nakamura S; Nagai R; Imanishi Y; Kameyama K; Ogawa K
Laryngoscope; 2022 Jan; 132(1):96-102. PubMed ID: 34245171
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness.
Park W; Park J; Park SI; Kim H; Bae H; Cho J; Won H; Park M; Jeong HS
Oral Oncol; 2019 Feb; 89():144-149. PubMed ID: 30732953
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
Choi SY; Lee E; Kim E; Chung MK; Son YI; Baek CH; Jeong HS
BMC Cancer; 2021 Feb; 21(1):178. PubMed ID: 33602169
[TBL] [Abstract][Full Text] [Related]
4. The presence of facial nerve weakness on diagnosis of a parotid gland malignant process.
Wierzbicka M; Kopeć T; Szyfter W; Kereiakes T; Bem G
Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1177-82. PubMed ID: 22179671
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Facial Nerve Outcome in Primary Parotid Cancer Surgery: A Population-Based Analysis.
Thielker J; Wahdan A; Buentzel J; Kaftan H; Boeger D; Mueller AH; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
Laryngoscope; 2021 Dec; 131(12):2694-2700. PubMed ID: 34050959
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Lymphocyte-to-Monocyte Ratio in Patients with Parotid Gland Carcinoma.
Mikoshiba T; Ozawa H; Watanabe Y; Sekimizu M; Saito S; Yoshihama K; Nakamura S; Imanishi Y; Kameyama K; Ogawa K
Laryngoscope; 2021 Mar; 131(3):E864-E869. PubMed ID: 32673437
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution.
Jouzdani E; Yachouh J; Costes V; Faillie JL; Cartier C; Poizat F; Pierre G; Burcia V; Makeieff M; Crampette L; Guerrier B; Garrel R
Eur J Cancer; 2010 Jan; 46(2):323-31. PubMed ID: 19931448
[TBL] [Abstract][Full Text] [Related]
8. Facial nerve paralysis caused by carcinoma developed in thorotrastoma in the parotid gland.
Johnsen NJ; Prytz S; Albrechtsen R
J Laryngol Otol; 1976 Jun; 90(6):571-5. PubMed ID: 778317
[TBL] [Abstract][Full Text] [Related]
9. Parotid Gland Tumors and the Facial Nerve.
Gandolfi MM; Slattery W
Otolaryngol Clin North Am; 2016 Apr; 49(2):425-34. PubMed ID: 27040587
[TBL] [Abstract][Full Text] [Related]
10. Basal cell adenocarcinoma of the parotid gland: Comparison with basal cell adenoma for preoperative diagnosis.
Terada T; Kawata R; Higashino M; Kurisu Y; Kuwabara H; Hirose Y
Auris Nasus Larynx; 2021 Apr; 48(2):310-316. PubMed ID: 32950324
[TBL] [Abstract][Full Text] [Related]
11. Malignant parotid gland tumors and facial nerve paralysis.
Katoh T; Ishige T; Kasai H; Naitoh J; Kaneko T; Kitamura T; Nagao K; Matsuzaki O
Arch Otorhinolaryngol; 1984; 240(2):139-44. PubMed ID: 6477291
[TBL] [Abstract][Full Text] [Related]
12. Perineural Invasion in Parotid Gland Malignancies.
Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer.
Busch A; Bauer L; Wardelmann E; Rudack C; Grünewald I; Stenner M
J Clin Pathol; 2017 May; 70(5):403-409. PubMed ID: 27729431
[TBL] [Abstract][Full Text] [Related]
14. Facial paralysis with an inflammatory parotid mass.
Halfpenny W; Bhandari R; Dunkley S
Int J Clin Pract; 2001; 55(6):413-4. PubMed ID: 11501234
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic analysis of 116 patients with mucoepidermoid carcinoma of the parotid gland].
Lu ZH; Yang AK; Chen ZX; Song M; Wei MW
Ai Zheng; 2007 Jul; 26(7):752-5. PubMed ID: 17626753
[TBL] [Abstract][Full Text] [Related]
16. Signs and symptoms of parotid gland carcinoma and their prognostic value.
Stodulski D; Mikaszewski B; Stankiewicz C
Int J Oral Maxillofac Surg; 2012 Jul; 41(7):801-6. PubMed ID: 22542080
[TBL] [Abstract][Full Text] [Related]
17. High expression of Livin serves as a predictive indicator for parotid gland tumors.
Xu H; Cheng Z; Liu DW; Chen L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5223-5228. PubMed ID: 31298372
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma of the Parotid Gland.
Liu Y; Su M; Yang Y; Zhao B; Qin L; Han Z
J Oral Maxillofac Surg; 2017 Feb; 75(2):416-422. PubMed ID: 27474461
[TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic factors in malignant parotid gland tumors.
Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
[TBL] [Abstract][Full Text] [Related]
20. Significance of intraparotid node metastasis in predicting local control in primary parotid cancer.
Feng Y; Liu F; Cheng G; Fang Q; Niu X; He W
Laryngoscope; 2019 Oct; 129(10):2309-2312. PubMed ID: 30549298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
